Skip to main content

Table 2 Early-phase stem cell studies in stroke: safety events

From: Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis

 

Experimental (n = 461)

Control (n = 329)

Death

16

27

Tumours

5

0

Seizures

21

5

Recurrent stroke

8

1

Haematoma

5

0

Pain

3

0

Infections

11

9

Fever

19

1

Headache

14

0